Literature DB >> 6778205

Dog GM1 gangliosidosis: characterization of the residual liver acid beta-galactosidase.

L S Rittmann, L L Tennant, J S O'Brien.   

Abstract

The residual liver acid beta-galactosidase activity from the first documented case of GM1 gangliosidosis in dogs was partially purified and characterized with respect to kinetic properties, thermostability, isoelectric point, molecular weight, and antigenicity. The GM1 dog liver beta-galactosidase appears to be identical with the normal dog liver enzyme in all properties examined. The canine disease is strikingly different from the human disease in the amount of enzyme that is present in the tissue. Unlike the human disease, in which normal amounts of catalytically defective beta-galactosidase are present, in dog GM1 gangliosidosis, only 1% of normal beta-galactosidase protein is detectable.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778205      PMCID: PMC1686169     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  Purification of human liver acid beta-D-galactosidases using affinity chromatography.

Authors:  A L Miller; R G Frost; J O'Brien
Journal:  Anal Biochem       Date:  1976-08       Impact factor: 3.365

2.  Binding of human liver beta-galactosidases to plant lectins insolubilized on agarose.

Authors:  A G Norden; J S O'Brien
Journal:  Biochem Biophys Res Commun       Date:  1974-01       Impact factor: 3.575

Review 3.  The statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1967

4.  Ganglioside GM1 beta-galactosidase: studies in human liver and brain.

Authors:  A G Norden; J S O'Brien
Journal:  Arch Biochem Biophys       Date:  1973-11       Impact factor: 4.013

5.  Immunological studies of beta galactosidase in normal human liver and in GM1 gangliosidosis.

Authors:  M Meisler; M C Rattazzi
Journal:  Am J Hum Genet       Date:  1974-11       Impact factor: 11.025

6.  Nature of the mutation in adult beta-galactosidase deficient patients.

Authors:  J S O'Brien; A G Norden
Journal:  Am J Hum Genet       Date:  1977-03       Impact factor: 11.025

7.  Biochemical and immunological studies of purified mouse beta-galactosidase.

Authors:  S Tomino; M Meisler
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

8.  Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency.

Authors:  D H Read; D D Harrington; T W Keenana; E J Hinsman
Journal:  Science       Date:  1976-10-22       Impact factor: 47.728

9.  An electrophoretic variant of beta-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis.

Authors:  A G Norden; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Quantitation of the enzymically deficient cross reacting material in GM1 gangliosidoses.

Authors:  Y Ben-Yoseph; B K Burton; H L Nadler
Journal:  Am J Hum Genet       Date:  1977-11       Impact factor: 11.025

View more
  2 in total

1.  Isolation and characterization of the normal canine beta-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis.

Authors:  Z H Wang; B Zeng; H Shibuya; G S Johnson; J Alroy; G M Pastores; S Raghavan; E H Kolodny
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

2.  Dog and human acid beta-D-galactosidases are structurally similar.

Authors:  J J Hubert; J S O'Brien
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.